Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Michael Steinmetz currently holds 3,759,735 shares of METABASIS THERAPEUTICS INC (MBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Steinmetz has been a net buyer of MBRX stock. They have purchased $5.0M and sold $3.7M worth of shares.
Michael Steinmetz's most recent insider trade was on Jun 19, 2012, when they sold 12,000 shares at $0.29 per share.
Michael Steinmetz serves as Executive at METABASIS THERAPEUTICS INC (MBRX). They have executed 32 insider transactions totaling $8.6M over their tenure at the company.
Michael Steinmetz holds the position of Executive at METABASIS THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Michael Steinmetz has shown a buying trading pattern, with $5.0M in total purchases and $3.7M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Michael Steinmetz was on Jun 19, 2008, when they sold $3.1M worth of VRUS shares. This transaction involved 153,700 shares at $19.90 per share.
Michael Steinmetz currently owns 3,759,735 shares of METABASIS THERAPEUTICS INC (MBRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Michael Steinmetz's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Michael Steinmetz has 32 Form 4 filings on record as an insider at METABASIS THERAPEUTICS INC.
Set alerts for Michael Steinmetz and 40,000+ other insiders.